Neogen Corporation Investing Cash Flow
Neogen Corporation (NEOG) reported Investing Cash Flow of $70.50 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-30
- Neogen Corporation net cash provided by (used in) investing activities for the quarter ending 2026-05-31 was -$4.00M.
- Neogen Corporation net cash provided by (used in) investing activities for the quarter ending 2026-02-28 was -$11.56M.
- Neogen Corporation net cash provided by (used in) investing activities for the quarter ending 2025-11-30 was -$11.67M.
- Neogen Corporation net cash provided by (used in) investing activities for the quarter ending 2025-08-31 was $97.72M.
- Neogen Corporation net cash provided by (used in) investing activities for fiscal 2026 was $70.50M.
- Neogen Corporation net cash provided by (used in) investing activities for fiscal 2025 was -$99.20M.
- Neogen Corporation net cash provided by (used in) investing activities for fiscal 2024 was -$29.30M, a 114.57% decline from fiscal 2023.
- Neogen Corporation net cash provided by (used in) investing activities for fiscal 2023 was $201.04M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$15.56M derived: sum of 2 quarters · filed 2026-07-30 | -$27.23M derived: sum of 3 quarters · filed 2026-07-30 | $70.50M 10-K · filed 2026-07-30 | ||
| 2026-02-28 | -$11.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$23.23M derived: sum of 2 quarters · filed 2026-04-09 | $74.50M 10-Q · filed 2026-04-09 | $58.60M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | -$11.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $86.06M 10-Q · filed 2026-01-08 | $70.16M derived: sum of 3 quarters · filed 2026-07-30 | $37.67M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $97.72M 10-Q · filed 2025-10-09 | $81.83M derived: sum of 2 quarters · filed 2026-07-30 | $49.34M derived: sum of 3 quarters · filed 2026-07-30 | $32.19M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | -$15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$48.38M derived: sum of 2 quarters · filed 2026-07-30 | -$65.54M derived: sum of 3 quarters · filed 2026-07-30 | -$99.20M 10-K · filed 2026-07-30 | -$99.19M 10-K · filed 2025-07-30 | |
| 2025-02-28 | -$32.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$49.64M derived: sum of 2 quarters · filed 2026-04-09 | -$83.30M 10-Q · filed 2026-04-09 | -$83.27M 10-Q · filed 2025-04-09 | -$100.81M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | -$17.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$50.82M 10-Q · filed 2026-01-08 | -$68.33M derived: sum of 3 quarters · filed 2026-07-30 | -$82.97M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | -$33.66M 10-Q · filed 2025-10-09 | -$51.18M derived: sum of 2 quarters · filed 2026-07-30 | -$65.81M derived: sum of 3 quarters · filed 2026-07-30 | -$54.28M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | -$17.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$32.15M derived: sum of 2 quarters · filed 2026-07-30 | -$20.62M derived: sum of 3 quarters · filed 2026-07-30 | -$29.30M 10-K · filed 2026-07-30 | -$29.31M 10-K · filed 2024-07-30 | |
| 2024-02-29 | -$14.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | -$3.10M derived: sum of 2 quarters · filed 2025-04-09 | -$11.79M 10-Q · filed 2025-04-09 | -$4.91M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-11-30 | $11.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $2.85M 10-Q · filed 2025-01-15 | $9.73M derived: sum of 3 quarters · filed 2025-07-30 | $29.25M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | -$8.68M 10-Q · filed 2024-10-10 | -$1.81M derived: sum of 2 quarters · filed 2025-07-30 | $17.71M derived: sum of 3 quarters · filed 2025-07-30 | $110.72M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-05-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $26.40M derived: sum of 2 quarters · filed 2025-07-30 | $119.40M derived: sum of 3 quarters · filed 2025-07-30 | $201.04M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | $19.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $112.53M derived: sum of 2 quarters · filed 2024-04-09 | $194.16M 10-Q · filed 2024-04-09 | $177.06M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-11-30 | $93.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $174.64M 10-Q · filed 2024-01-09 | $157.54M derived: sum of 3 quarters · filed 2024-07-30 | $142.16M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-08-31 | $81.64M 10-Q · filed 2023-10-10 | $64.54M derived: sum of 2 quarters · filed 2024-07-30 | $49.15M derived: sum of 3 quarters · filed 2024-07-30 | $9.82M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-05-31 | -$17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$32.48M derived: sum of 2 quarters · filed 2024-07-30 | -$71.82M derived: sum of 3 quarters · filed 2024-07-30 | -$97.23M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | -$15.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | -$54.72M derived: sum of 2 quarters · filed 2023-04-04 | -$80.13M 10-Q · filed 2023-04-04 | -$111.84M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-11-30 | -$39.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$64.74M 10-Q · filed 2023-01-09 | -$96.45M derived: sum of 3 quarters · filed 2023-08-15 | -$157.37M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-08-31 | -$25.41M 10-Q · filed 2022-09-30 | -$57.12M derived: sum of 2 quarters · filed 2023-08-15 | -$118.03M derived: sum of 3 quarters · filed 2023-08-15 | -$95.24M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-05-31 | -$31.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | -$92.63M derived: sum of 2 quarters · filed 2023-08-15 | -$69.83M derived: sum of 3 quarters · filed 2023-08-15 | -$105.56M 10-K · filed 2023-08-15 | ||
| 2021-02-28 | -$60.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | -$38.12M derived: sum of 2 quarters · filed 2022-04-01 | -$73.85M 10-Q · filed 2022-04-01 | -$86.06M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-11-30 | $22.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | -$12.94M 10-Q · filed 2021-12-30 | -$25.14M derived: sum of 3 quarters · filed 2022-07-27 | -$68.09M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-08-31 | -$35.73M 10-Q · filed 2021-09-30 | -$47.94M derived: sum of 2 quarters · filed 2022-07-27 | -$90.89M derived: sum of 3 quarters · filed 2022-07-27 | -$109.16M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-05-31 | -$12.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | -$55.16M derived: sum of 2 quarters · filed 2022-07-27 | -$73.42M derived: sum of 3 quarters · filed 2022-07-27 | -$88.78M 10-K · filed 2022-07-27 | ||
| 2020-02-29 | -$42.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | -$61.22M derived: sum of 2 quarters · filed 2021-03-31 | -$76.58M 10-Q · filed 2021-03-31 | -$152.09M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-11-30 | -$18.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | -$33.63M 10-Q · filed 2020-12-29 | -$109.14M derived: sum of 3 quarters · filed 2021-07-30 | -$129.50M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-08-31 | -$15.36M 10-Q · filed 2020-09-30 | -$90.88M derived: sum of 2 quarters · filed 2021-07-30 | -$111.24M derived: sum of 3 quarters · filed 2021-07-30 | -$126.94M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-05-31 | -$75.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | -$95.88M derived: sum of 2 quarters · filed 2021-07-30 | -$111.57M derived: sum of 3 quarters · filed 2021-07-30 | -$119.15M 10-K · filed 2021-07-30 | ||
| 2019-02-28 | -$20.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -$36.06M derived: sum of 2 quarters · filed 2020-04-03 | -$43.63M 10-Q · filed 2020-04-03 | -$65.93M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-11-30 | -$15.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | -$23.27M 10-Q · filed 2019-12-27 | -$45.57M derived: sum of 3 quarters · filed 2020-07-30 | -$50.13M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-08-31 | -$7.57M 10-Q · filed 2019-09-26 | -$29.87M derived: sum of 2 quarters · filed 2020-07-30 | -$34.44M derived: sum of 3 quarters · filed 2020-07-30 | -$50.77M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-05-31 | -$22.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | -$26.86M derived: sum of 2 quarters · filed 2020-07-30 | -$43.20M derived: sum of 3 quarters · filed 2020-07-30 | -$83.08M 10-K · filed 2020-07-30 | ||
| 2018-02-28 | -$4.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | -$20.91M derived: sum of 2 quarters · filed 2019-03-29 | -$60.79M 10-Q · filed 2019-03-29 | |||
| 2017-11-30 | -$16.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | -$56.22M 10-Q · filed 2018-12-28 | ||||
| 2017-08-31 | -$39.88M 10-Q · filed 2018-10-05 | |||||
| 2017-05-31 | -$62.14M 10-K · filed 2019-07-30 | |||||
| 2016-05-31 | -$61.15M 10-K · filed 2018-07-27 | |||||
| 2014-05-31 | -$14.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | -$24.58M derived: sum of 2 quarters · filed 2014-07-30 | -$33.81M derived: sum of 3 quarters · filed 2014-07-30 | -$51.29M 10-K · filed 2014-07-30 | ||
| 2014-02-28 | -$10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | -$19.32M derived: sum of 2 quarters · filed 2014-04-04 | -$36.81M 10-Q · filed 2014-04-04 | -$48.37M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-11-30 | -$9.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | -$26.71M 10-Q · filed 2014-01-09 | -$38.27M derived: sum of 3 quarters · filed 2014-07-30 | -$41.45M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-08-31 | -$17.48M 10-Q · filed 2013-09-30 | -$29.04M derived: sum of 2 quarters · filed 2014-07-30 | -$32.22M derived: sum of 3 quarters · filed 2014-07-30 | -$43.09M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2013-05-31 | -$11.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | -$14.73M derived: sum of 2 quarters · filed 2014-07-30 | -$25.61M derived: sum of 3 quarters · filed 2014-07-30 | -$37.95M 10-K · filed 2014-07-30 | ||
| 2013-02-28 | -$3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | -$14.05M derived: sum of 2 quarters · filed 2014-04-04 | -$26.39M 10-Q · filed 2014-04-04 | -$26.23M 10-Q · filed 2013-03-28 | -$32.15M derived: sum of 4 quarters · filed 2014-07-30 | |
| 2012-11-30 | -$10.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | -$23.22M 10-Q · filed 2014-01-09 | -$28.97M derived: sum of 3 quarters · filed 2014-07-30 | -$30.90M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-08-31 | -$12.34M 10-Q · filed 2013-09-30 | -$18.10M derived: sum of 2 quarters · filed 2014-07-30 | -$20.02M derived: sum of 3 quarters · filed 2014-07-30 | -$11.40M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-05-31 | -$5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | -$7.68M derived: sum of 2 quarters · filed 2014-07-30 | $939.00K derived: sum of 3 quarters · filed 2014-07-30 | -$15.79M 10-K · filed 2014-07-30 | ||
| 2012-02-29 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $6.69M derived: sum of 2 quarters · filed 2013-03-28 | -$10.03M 10-Q · filed 2013-03-28 | -$15.27M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-11-30 | $8.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | -$8.11M 10-Q · filed 2012-12-28 | -$13.35M derived: sum of 3 quarters · filed 2013-07-30 | -$15.41M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-08-31 | -$16.72M 10-Q · filed 2012-09-28 | -$21.96M derived: sum of 2 quarters · filed 2013-07-30 | -$24.02M derived: sum of 3 quarters · filed 2013-07-30 | -$32.24M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-05-31 | -$5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | -$7.30M derived: sum of 2 quarters · filed 2013-07-30 | -$15.52M derived: sum of 3 quarters · filed 2013-07-30 | -$28.04M 10-K · filed 2013-07-30 | ||
| 2011-02-28 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | -$10.28M derived: sum of 2 quarters · filed 2012-03-30 | -$22.80M 10-Q · filed 2012-03-30 | |||
| 2010-11-30 | -$8.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | -$20.73M 10-Q · filed 2011-12-30 | ||||
| 2010-08-31 | -$12.52M 10-Q · filed 2011-09-30 | |||||
| 2010-05-31 | -$25.73M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |